Uzun, G. S. Et Al. 2025. ACPA is a main risk factor for CT-proven pulmonary nodule progression in patients with rheumatoid arthritis. CLINICAL RHEUMATOLOGY , no.3 , 1031-1040.

Uzun, G. S., SARIKAYA, Y., Arslan, S., EKİCİ, M., ATA, E. B., KARCIOĞLU, O., ... BİLGİN, E.(2025). ACPA is a main risk factor for CT-proven pulmonary nodule progression in patients with rheumatoid arthritis. CLINICAL RHEUMATOLOGY , no.3, 1031-1040.

Uzun, Gullu Et Al. "ACPA is a main risk factor for CT-proven pulmonary nodule progression in patients with rheumatoid arthritis," CLINICAL RHEUMATOLOGY , no.3, 1031-1040, 2025

Uzun, Gullu S. Et Al. "ACPA is a main risk factor for CT-proven pulmonary nodule progression in patients with rheumatoid arthritis." CLINICAL RHEUMATOLOGY , no.3, pp.1031-1040, 2025

Uzun, G. S. Et Al. (2025) . "ACPA is a main risk factor for CT-proven pulmonary nodule progression in patients with rheumatoid arthritis." CLINICAL RHEUMATOLOGY , no.3, pp.1031-1040.

@article{article, author={Gullu Sandal Uzun Et Al. }, title={ACPA is a main risk factor for CT-proven pulmonary nodule progression in patients with rheumatoid arthritis}, journal={CLINICAL RHEUMATOLOGY}, year=2025, pages={1031-1040} }